An evaluation of the FDA's analysis of the costs and benefits of the graphic warning label regulation
The Family Smoking Prevention and Tobacco Control Act of 2009 gave the Food and Drug Administration (FDA) regulatory authority over cigarettes and smokeless tobacco products and authorised it to assert jurisdiction over other tobacco products. As with other Federal agencies, FDA is required to asses...
| Main Authors: | , , , , , , , , |
|---|---|
| Other Authors: | |
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group,
2015-03-11T15:07:47Z.
|
| Subjects: | |
| Online Access: | Get fulltext |